Epidemiology of interstitial lung diseases in Greece

Respiratory Medicine

Volumn 103, Issue 8, 2009, Pages 1122-1129

  Karakatsani, A ^a   Papakosta, D ^b   Rapti, A ^c   Antoniou, K M ^d   Dimadi, M ^c   Markopoulou, A ^e   Latsi, P ^f   Polychronopoulos, V ^g   Birba, G ^c   Ch, Labrakis ^c   Bouros, D ^h  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c SOTIRIA GENERAL HOSPITAL   (Greece)

^d UNIVERSITY OF CRETE   (Greece)

^e G Papanikolaou Hospital   (Greece)

^f UNIVERSITY OF ATHENS   (Greece)

^g Sismanoglion General District Hospital   (Greece)

^h DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Epidemiology; Greece; Idiopathic interstitial pneumonias; Idiopathic pulmonary fibrosis; Interstitial lung diseases; Registry

Indexed keywords

ALLERGIC PNEUMONITIS; ARTICLE; COLLAGEN DISEASE; DISEASE ASSOCIATION; FEMALE; FIBROSING ALVEOLITIS; GREECE; HISTIOCYTOSIS; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SARCOIDOSIS; VASCULAR DISEASE;

FEMALE; GREECE; HEALTH SURVEYS; HUMANS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MALE; PREVALENCE; PROGNOSIS; QUESTIONNAIRES;

EID: 67649195440     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.03.001     Document Type: Article

References (32)

1. American Thoracic Society/European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165 (2002) 277-304
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International Consensus Statement. Am J Respir Crit Care Med 161 (2000) 646-664
3. Bouros D. Current classification of idiopathic interstitial pneumonias. Monaldi Arch Chest Dis 55 (2000) 450-454
4. Verleden G.M., Du Bois R.M., Bouros D., et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin. Eur Respir J 18 32 (2001) 17s-29s
5. Bouros D., and Antoniou K.M. Current and future treatment approaches in idiopathic pulmonary fibrosis. Eur Respir J 16 (2005) 693-703
6. Coultas D.B., Zumwalt R.E., Black W.C., and Sobonya R.E. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 150 (1994) 967-972
7. Schweisfurth H. Mitteilung der wissenschaftliches Arbeitsgemeinschaft für die Therapie Lungenkrankheiten (WATL): Deutsches Fibrosereregister mit ernsten Ergebnissen. Pneumologie 50 (1996) 899-901
8. Schweisfurth H., Kieslich C., Satake N., et al. How are interstitial lung diseases diagnosed in Germany? Results of the scientific registry for the exploration of interstitial lung diseases ("Fibrosis registry") of the WATL. Pneumologie 57 (2003 Jul) 373-382
9. Thomeer M, Demetds M, Vandeurzen K and the VRGT working group on Interstitial Lung diseases. Registration of interstitial lung diseases in 20 centers of respiratory medicine in Flanders. Acta Clin Belg 56 (2001) 163-172
10. Roelandt M, Demedts M, Callebaut W, et al. Working group on ILD. Epidemiology of interstitial lung diseases in Flanders registration by pneumologists in 1992-1994. Acta Clin Belg 50-55 (1995) 260-268
11. Agostini C., Albera C., Bariffi F., et al. First report of the Italian register for diffuse lung disorders (RIPID). Monaldi Arch Chest Dis 56 (2001) 364-368
12. Tinelli C., De Silvestri A., Richeldi L., and Oggionni T. The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report. Sarcoidosis Vasc Diffuse Lung Dis 22 1 (2005) S4-S8
13. Xaubet A., Ancochea J., Morell F., et al. Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis 21 (2004) 64-70
14. Lopez-Campos JL, Rodriguez-Becerra E; Neumosur Task Group; Registry of Interstitial Lung Diseases. Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study. Eur J Epidemiol 19 (2004) 155-161
15. Demedts M., Wells A.U., Antó J.M., et al. Interstitial lung diseases: an epidemiological overview. Eur Respir J 18 32 (2001) 2s-16s
16. Thomeer M.J., Costabel U., Rizzato G., Poletti V., and Demedts M. Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J 18 32 (2001) 114s-118s
17. Hodgson U., Laitinen T., and Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 57 (2002) 338-342
18. Byg K.F., Milman N., and Hansen S. Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 20 (2003) 46-52
19. Nicholson A.G., Colby T.V., and Wells A.U. Histopathological approach to patterns of interstitial pneumonia in patients with connective tissue disorders. Sarcoidosis Vasc Diffuse Lung Dis 19 (2002) 10-17
20. Bouros D., Wells A.U., Nicholson A.G., et al. Histopathological subsets of fibrosing alveolitis in patients with systemic sclerosis and their relation to outcome. Am J Respir Crit Care Med 165 (2002) 1581-1586
21. Bjoraker J.A., Ryu J.H., Edwin M.K., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157 (1998) 199-203
22. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). February 1999. Statement on sarcoidosis. Am J Respir Crit Care Med 160 (1999) 736-755 (Adopted by the ATS Board of Directors and by the ERS Executive Committee)
23. Nicholson A.G., Colby T.V., du Bois R.M., Hansell D.M., and Wells A.U. The prognostic significance of the histological pattern of idiopathic pneumonias in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162 (2000) 2213-2217
24. Nagai S., Kitaichi M., Itoh H., Nishimura K., Izumi T., and Colby T.V. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 12 (1998) 1010-1019
25. Travis W.D., Matsui K., Moss J., and Ferrans V.J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns-survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24 (2000) 19-33
26. Flaherty K.R., Travis W.D., Colby T.V., et al. Histopathological variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164 (2001) 1722-1727
27. Hartman T.E., Swensen S.J., Hansell D.M., et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 217 (2000) 701-705
28. Bourke S.J., Dalphin J.C., Boyd G., McSharry C., Baldwin C.I., and Calvert J.E. Hypersensitivity pneumonitis: current concepts. Eur Respir J 18 32 (2001) 81s-92s
29. Kim D.S. Sarcoidosis in Korea: report of the second nationwide survey. Sarcoidosis Vasc Diffuse Lung Dis 18 (2001) 176-180
30. Bresnitz E.A., and Strom B.L. Epidemiology of sarcoidosis. Epidemiol Rev 5 (1983) 124-156
31. Morimoto T., Azuma A., Abe S., Usuki J., Kudoh S., Sugisaki K., Oritsu M., and Nukiwa T. Epidemiology of sarcoidosis in Japan. Eur Respir J 31 (2008) 372-379
32. Fité E., Alsina J.M., Maňá J., Pujol R., Ruiz J., and Morera J. Epidemiology of sarcoidosis in Catalonia: 1979-1989. Sarcoidosis Vasc Diffuse Lung Dis 13 (1996) 153-158